The role of 2-hydroxyglutarate magnetic resonance spectroscopy for the determination of isocitrate dehydrogenase status in lower grade gliomas versus glioblastoma: a systematic review and meta-analysis of diagnostic test accuracy

被引:18
作者
Bhandari, Abhishta [1 ]
Sharma, Chinmay [2 ]
Ibrahim, Muhammad [2 ]
Riggs, Matthew [1 ]
Jones, Rhondda [2 ]
Lasocki, Arian [3 ,4 ]
机构
[1] Townsville Univ Hosp, 100 Angus Smith Dr, Douglas, Qld 4814, Australia
[2] James Cook Univ, Townsville, Qld, Australia
[3] Peter MacCallum Canc Ctr, Dept Canc Imaging, Melbourne, Vic, Australia
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
关键词
Magnetic resonance spectroscopy; isocitrate dehydrogenase; glioma; glioblastoma; IDH;
D O I
10.1007/s00234-021-02702-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose Magnetic resonance spectroscopy (MRS) provides a non-invasive means of determining isocitrate dehydrogenase (IDH) status. Determination of 2-hydroxyglutarate (2-HG) presence through MRS is a means of determining IDH status; however, differences may be seen by grade. The goal of this paper is to perform a diagnostic test accuracy (DTA) meta-analysis on 2-HG MRS for IDH status in both lower-grade glioma (LGG) and glioblastoma (GBM) in preoperative patients. Methods A systematic review and meta-analysis were performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Diagnostic Test Accuracy guidelines. Quality assessment was performed using the Quality Assessment of Diagnostic Accuracy Studies 2. The search was up to date as of 09/02/2021. Nine English-language journal articles were included. Results The meta-analysis found a pooled sensitivity of 93% (95% CI 58-99%) and specificity of 84% (95% CI 51-96%) for LGG (n= 181). For GBM (n= 77), the pooled sensitivity was 84% (95% CI 25.0-99%) and the specificity was 97% (95% CI 43-100%). Conclusion 2-HG MRS shows promise as a non-invasive means of determining IDH status, with specificity higher for GBM and sensitivity higher for LGG. The wide confidence intervals are notable, however, in particular related to the small number of IDH-mutant GBM studied. Diagnostic heterogeneity was particularly present for LGG, and the hierarchical summary receiver operator curves showed poor predictive accuracy in both groups. For more conclusive results, diagnostic test accuracy statistics need to be quantified with larger studies and more deliberate study design.
引用
收藏
页码:1823 / 1830
页数:8
相关论文
共 28 条
[1]   Precision oncology in the era of radiogenomics: the case of D-2HG as an imaging biomarker for mutant IDH gliomas [J].
Andronesi, Ovidiu C. .
NEURO-ONCOLOGY, 2018, 20 (07) :865-867
[2]   Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic Review [J].
Bhandari, A. P. ;
Liong, R. ;
Koppen, J. ;
Murthy, S. V. ;
Lasocki, A. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2021, 42 (01) :94-101
[3]   Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy [J].
Branzoli, Francesca ;
Pontoizeau, Clement ;
Tchara, Lucien ;
Di Stefano, Anna Luisa ;
Kamoun, Aurelie ;
Deelchand, Dinesh K. ;
Valabregue, Romain ;
Lehericy, Stephane ;
Sanson, Marc ;
Ottolenghi, Chris ;
Marjanska, Malgorzata .
NEURO-ONCOLOGY, 2019, 21 (06) :765-774
[4]   Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy [J].
Branzoli, Francesca ;
Di Stefano, Anna Luisa ;
Capelle, Laurent ;
Ottolenghi, Chris ;
Valabregue, Romain ;
Deelchand, Dinesh K. ;
Bielle, Franck ;
Villa, Chiara ;
Baussart, Bertrand ;
Lehericy, Stephane ;
Sanson, Marc ;
Marjanska, Malgorzata .
NEURO-ONCOLOGY, 2018, 20 (07) :907-916
[5]   2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas [J].
Choi, Changho ;
Ganji, Sandeep K. ;
DeBerardinis, Ralph J. ;
Hatanpaa, Kimmo J. ;
Rakheja, Dinesh ;
Kovacs, Zoltan ;
Yang, Xiao-Li ;
Mashimo, Tomoyuki ;
Raisanen, Jack M. ;
Marin-Valencia, Isaac ;
Pascual, Juan M. ;
Madden, Christopher J. ;
Mickey, Bruce E. ;
Malloy, Craig R. ;
Bachoo, Robert M. ;
Maher, Elizabeth A. .
NATURE MEDICINE, 2012, 18 (04) :624-629
[6]   2-Hydroxyglutarate Detection by Short Echo Time Magnetic Resonance Spectroscopy in Routine Imaging Study of Brain Glioma at 3.0 T [J].
Crisi, Girolamo ;
Filice, Silvano ;
Michiara, Maria ;
Crafa, Pellegrino ;
Lana, Silvia .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2018, 42 (03) :469-474
[7]   In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naive suspect lower-grade gliomas: feasibility and accuracy in a clinical setting [J].
Cuccarini, Valeria ;
Antelmi, Luigi ;
Pollo, Bianca ;
Paterra, Rosina ;
Calatozzolo, Chiara ;
Nigri, Anna ;
DiMeco, Francesco ;
Eoli, Marica ;
Finocchiaro, Gaetano ;
Brenna, Greta ;
Tramacere, Irene ;
Bruzzone, Maria Grazia ;
Anghileri, Elena .
NEUROLOGICAL SCIENCES, 2020, 41 (02) :347-355
[8]   Magnetic Resonance Spectroscopic Assessment of Isocitrate Dehydrogenase Status in Gliomas: The New Frontiers of Spectrobiopsy in Neurodiagnostics [J].
Di Ieva, Antonio ;
Magnussen, John S. ;
McIntosh, Jeffery ;
Mulcahy, Michael J. ;
Pardey, Margery ;
Choi, Changho .
WORLD NEUROSURGERY, 2020, 133 :E421-E427
[9]  
Dwamena B, 2007, MIDAS STATA MODULE M
[10]   metandi: Meta-analysis of diagnostic accuracy using hierarchical logistic regression [J].
Harbord, Roger M. ;
Whiting, Penny .
STATA JOURNAL, 2009, 9 (02) :211-229